Medscape

Genetic Testing Warranted in Epilepsy of Unknown Origin

ORLANDO — Genetic testing is warranted in patients with epilepsy of unknown origin, new research suggests. Investigators found that pathogenic genetic variants were identified in over 40% of patients ...
Healio

Genetic testing beneficial as a diagnostic tool for adults with epilepsy

Please provide your email address to receive an email when new articles are posted on . The study included 250 patients with epilepsy. A history of delayed development and earlier seizure onset were ...
Nasdaq

GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners

STAMFORD, Conn.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...
Healio

Barriers to genetic testing in lower income regions drive disparities in epilepsy

Please provide your email address to receive an email when new articles are posted on . A limited understanding of non-European DNA may hinder genetic testing interpretations, leading to disparities ...
Medscape

Noninvasive Testing in Midlife Flags Late-Onset Epilepsy Risk

Noninvasive tests performed in midlife may help identify people who are at risk of late-onset epilepsy (LOE), a new study suggests. New data from the Framingham Heart Study show those who scored ...
Nasdaq

GeneDx expands access to exome testing for pediatric epilepsy patients

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side analysts ...
Seeking Alpha

GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients

STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the first-of-its-kind patient access ...
News Medical

ADD Program receives $19.5 million NIH contract to test drugs for treating epilepsy

The University of Utah College of Pharmacy's Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of Health (NIH) to ...
EurekAlert!

Epilepsy could become easier to pinpoint with blood test

Researchers from Lund University in Sweden have discovered higher levels of immune proteins in the blood before and after an epileptic seizure. The possible biomarkers can be identified using a simple ...

Accreditation recognizes Springfield Memorial’s epilepsy expertise

Springfield Memorial Hospital has been accredited as a Level 4 Epilepsy Center, recognizing advanced testing and treatment ...
ABC7

Yale researchers have developed AI test to more accurately evaluate drivers with epilepsy

NEW HAVEN, Conn. (KABC) -- Every state has different requirements when it comes to driving with epilepsy. Here in California, patients must be seizure-free for a specific period of time and submit a ...